This program is intended for registered nurses, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.
Upon completion of this activity, participants should be able to:
Joseph J. Eron Jr., MD
Herman and Louise Smith Distinguished Professor of Medicine
Chief, Division of Infectious Diseases
UNC-Chapel Hill School of Medicine
Chapel Hill, North Carolina
Joseph J. Eron, Jr., MD: consultant/advisor/speaker: Gilead Sciences, GlaxoSmithKline, Janssen, Merck, ViiV; researcher: Gilead Sciences, ViiV.
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, FAANP, FAAN
Division of Advanced Nursing Practice
Rutgers School of Nursing
Newark, New Jersey
Gotham Medical Group
New York, New York
Jeffrey Kwong, DNP, MPH, FAANP, FAAN, has no relevant conflicts of interest to report.
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP, has disclosed that she has received consultant/advisor/speaker fees from Gilead Sciences, Janssen, Merck, Theratechnologies, and ViiV Healthcare.
Christopher Fox, MSN, RN, ANP-BC, AAHIVS
Assistant Professor of Medicine
Division of General Internal Medicine & Geriatrics
Internal Medicine Clinic / HIV Clinic
Oregon Health & Science University
Christopher Fox, MSN, RN, ANP-BC, AAHIVS, has no relevant conflicts of interest to report.
Jessica L. Adams, PharmD, AAHIVE
Scientific Director, Infectious Diseases
Clinical Care Options
New York, United States
Jessica Adams, PharmD, has no relevant conflicts of interest to report.
Petra Cravens, PhD
Petra Cravens, PhD, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc, ELS
Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-154-H02-P.
Type of Activity: Application
Upon successfully completing the post-test with a score of 50% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 14, 2022, through June 13, 2023:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 50% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
This program has been made available online.
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary ARV regimens.